SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales surged to Rs. 3041.61 millions, up 38.29% for the March 2025 quarter as against Rs. 2199.38 millions during the corresponding quarter previous year.Profit for the quarter ended March 2025 rises by 95.91% to Rs. 628.48  millions from Rs. 320.80 millions.Operating Profit saw a handsome growth to 897.52 millions from 487.07 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 3041.61 2199.38 38.29 9898.35 6875.83 43.96 9898.35 6875.83 43.96
Other Income 56.94 85.54 -33.43 183.36 137.86 33.00 183.36 137.86 33.00
PBIDT 897.52 487.07 84.27 2434.78 1214.53 100.47 2434.78 1214.53 100.47
Interest 3.83 20.56 -81.37 58.57 58.94 -0.63 58.57 58.94 -0.63
PBDT 893.69 466.51 91.57 2376.21 838.05 183.54 2376.21 838.05 183.54
Depreciation 65.56 43.63 50.26 240.45 146.94 63.64 240.45 146.94 63.64
PBT 828.13 422.88 95.83 2135.76 691.11 209.03 2135.76 691.11 209.03
TAX 199.65 102.08 95.58 540.29 254.25 112.50 540.29 254.25 112.50
Deferred Tax 47.36 29.02 63.20 70.58 45.12 56.43 70.58 45.12 56.43
PAT 628.48 320.80 95.91 1595.47 436.86 265.21 1595.47 436.86 265.21
Equity 409.34 368.81 10.99 409.34 368.81 10.99 409.34 368.81 10.99
PBIDTM(%) 29.51 22.15 33.24 24.60 17.66 39.26 24.60 17.66 39.26

Acutaas Chemicals Share Price

2393.75 30.10 (1.27%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×